Accreditation and Designation User Manual - OECI
Accreditation and Designation User Manual - OECI
Accreditation and Designation User Manual - OECI
Create successful ePaper yourself
Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.
1.4.12. Registration <strong>and</strong> evaluation of the recommendations of the multidisciplinary team meeting<br />
Have agreements been reached concerning the registration <strong>and</strong> evaluation of recommendations that emerge from the<br />
multidisciplinary team meeting?<br />
1.4.12.1.<br />
1.4.12.1.1. Conclusions <strong>and</strong> advice resulting from the<br />
multidisciplinary team meeting are documented<br />
in the patient’s medical record<br />
1.4.12.1.2. Deviations from conclusions <strong>and</strong> advice are<br />
documented <strong>and</strong> motivated in the patient’s medical<br />
record<br />
1.4.12.1.3. There is a procedure described on how the<br />
conclusions <strong>and</strong> advice from the multidisciplinary<br />
meeting will be evaluated <strong>and</strong> by whom.<br />
Yes Mostly Partially No not applicable<br />
1.5. Safeguarding the quality system<br />
1.5.1. Quality <strong>and</strong> risk management <strong>and</strong> safety requirements<br />
Does the cancer centre have a global policy for quality <strong>and</strong> risk management <strong>and</strong> safety requirements?<br />
1.5.1.1.<br />
1.5.1.1.1. There is an identified Quality <strong>and</strong> Risk<br />
Management Direction<br />
1.5.1.1.2. The quality Director participates in the executive<br />
direction of the cancer centre<br />
1.5.1.1.3. There is a written global programme describing<br />
the policy for: Quality management, including<br />
continuous quality improvement (CQI) certification<br />
processes <strong>and</strong> individual accreditation of physicians<br />
1.5.1.1.4. There is a written global programme describing<br />
the policy for: Risk management, including a<br />
programme for the centralised reporting of<br />
undesirable events by health care workers<br />
1.5.1.1.5. There is a written global programme describing<br />
the policy for: Safety management of the cancer<br />
centre <strong>and</strong> its users<br />
1.5.1.1.6. There is a written global programme describing<br />
the policy for: Patient safety management, including<br />
a systematic centralised reporting of side effects<br />
of drugs (current practice)<br />
1.5.1.1.7. There is a programme for the systemic analysis<br />
of major adverse or undesirable events<br />
(e.g.: morbidity <strong>and</strong> mortality reviews), in each<br />
clinical <strong>and</strong> technical department<br />
1.5.1.1.8. Patients or patients’ relatives should be part of<br />
these organisations<br />
Yes Mostly Partially No not applicable<br />
10 / <strong>OECI</strong> <strong>Accreditation</strong> <strong>and</strong> <strong>Designation</strong> / Appendix II